Evolus Inc. (EOLS) stock falls on Q1 2026 Earnings

Evolus Inc. (EOLS) reported first-quarter 2026 revenue of $73.1 million, up 6.7% year-over-year, slightly below the consensus revenue estimate of $73.7 million.

Gross profit: $48.9 million (up 4.8% YoY)

Cost of sales: $24.2 million (up 10.9% YoY)

Operating result: -$6.8 million (operating profit declined 54.9% YoY)

Net income attributable to common shareholders: -$10.7 million (down 43.5% YoY)

Diluted EPS: -0.16 (down 46.7% YoY)

Cash from operating activities: $12.8 million (down 182.1% YoY)

Purchases of property, plant and equipment: -$1.5 million (up 363.6% YoY)

Cash and cash equivalents: $49.8 million (down 26.7% YoY)

Total liabilities: $249.4 million (up 13.4% YoY)

Consensus EPS estimate: -0.1326; stock moved -4.88% since market close.

Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.

Evolus Inc. Insider Trading Activity

Evolus Inc. insiders have traded $EOLS stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.

Here’s a breakdown of recent trading of $EOLS stock by insiders over the last 6 months:

DAVID MOATAZEDI (See Remarks) has made 0 purchases and 3 sales selling 140,928 shares for an estimated $710,852.
RUI AVELAR (See Remarks) has made 0 purchases and 3 sales selling 35,376 shares for an estimated $177,612.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.

EARLY ACCESS

Receive EOLS Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

Evolus Inc. Hedge Fund Activity

We have seen 90 institutional investors add shares of Evolus Inc. stock to their portfolio, and 85 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

TANG CAPITAL MANAGEMENT LLC removed 4,242,607 shares (-77.3%) from their portfolio in Q4 2025, for an estimated $28,213,336
CALIGAN PARTNERS LP removed 4,138,943 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $27,523,970
BRAIDWELL LP added 3,105,209 shares (+inf%) to their portfolio in Q4 2025, for an estimated $20,649,639
EVERSEPT PARTNERS, LP removed 1,131,005 shares (-76.7%) from their portfolio in Q4 2025, for an estimated $7,521,183
ARMISTICE CAPITAL, LLC added 976,000 shares (+inf%) to their portfolio in Q4 2025, for an estimated $6,490,400
BOOTHBAY FUND MANAGEMENT, LLC removed 927,889 shares (-90.1%) from their portfolio in Q4 2025, for an estimated $6,170,461
CITADEL ADVISORS LLC added 790,722 shares (+134.4%) to their portfolio in Q4 2025, for an estimated $5,258,301

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.

Evolus Inc. Analyst Ratings

Wall Street analysts have issued reports on $EOLS in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

HC Wainwright & Co. issued a "Buy" rating on 02/03/2026
BTIG issued a "Buy" rating on 01/22/2026
Mizuho issued a "Outperform" rating on 12/02/2025

To track analyst ratings and price targets for Evolus Inc., check out Quiver Quantitative's $EOLS forecast page.

Evolus Inc. Price Targets

Multiple analysts have issued price targets for $EOLS recently. We have seen 4 analysts offer price targets for $EOLS in the last 6 months, with a median target of $15.0.

Here are some recent targets:

Sam Eiber from BTIG set a target price of $13.0 on 03/04/2026
Douglas Tsao from HC Wainwright & Co. set a target price of $13.0 on 02/03/2026
Annabel Samimy from Stifel set a target price of $17.0 on 01/13/2026
Uy Ear from Mizuho set a target price of $19.0 on 12/02/2025